Getting to First-in-Human for Small Molecules and Biologics

  Рет қаралды 4,343

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
56:31
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
U.S. Food and Drug Administration
Рет қаралды 3,3 М.
Designing First-In-Human Trials for Small Molecules and Biologics
37:34
Designing First-In-Human Trials for Small Molecules and Biologics
U.S. Food and Drug Administration
Рет қаралды 11 М.
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
21:38
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
Я ОТ САКЕ
Рет қаралды 1,5 МЛН
My daughter-in-law finally praised me# Laotie smiled# made a good play every day# photosynthesis pl
00:34
My daughter-in-law finally praised me# Laotie smiled# made a good play every day# photosynthesis pl
Fengjie Family Joke
Рет қаралды 7 МЛН
☝️☝️☝️МАЛЫШ-СИЛАЧ 14 лет притворился НОВИЧКОМ | Школьник сделал то, чего не смог качок
00:50
☝️☝️☝️МАЛЫШ-СИЛАЧ 14 лет притворился НОВИЧКОМ | Школьник сделал то, чего не смог качок
Nikita Zdradovskiy
Рет қаралды 2,3 МЛН
Увеличили моцареллу для @Lorenzo.bagnati
00:48
Увеличили моцареллу для @Lorenzo.bagnati
Кушать Хочу
Рет қаралды 9 МЛН
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
44:31
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
U.S. Food and Drug Administration
Рет қаралды 12 М.
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
36:56
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
U.S. Food and Drug Administration
Рет қаралды 7 М.
Updates on FDA’s Drug-Drug Interaction Final Guidances
1:24:58
Updates on FDA’s Drug-Drug Interaction Final Guidances
U.S. Food and Drug Administration
Рет қаралды 9 М.
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
54:28
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 16 М.
FDA Oncology Drug Development Overview - Past to Present
29:20
FDA Oncology Drug Development Overview - Past to Present
U.S. Food and Drug Administration
Рет қаралды 4,2 М.
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine
37:46
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine
U.S. Food and Drug Administration
Рет қаралды 3,2 М.
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2)
2:19:09
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2)
U.S. Food and Drug Administration
Рет қаралды 9 М.
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 23 М.
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
U.S. Food and Drug Administration
Рет қаралды 10 М.
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
46:00
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 20 М.
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
21:38
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
Я ОТ САКЕ
Рет қаралды 1,5 МЛН